(Q43185530)

15 November 2017

title

Acceptability and adherence: findings from a Phase II study of a candidate vaginal microbicide, 'Praneem polyherbal tablet', in Pune, India (English)

1 reference

15 November 2017

1 reference

N S Joglekar

1

1 reference

15 November 2017

S N Joshi

2

1 reference

15 November 2017

S S Deshpande

3

1 reference

15 November 2017

A N Parkhe

4

1 reference

15 November 2017

U R Katti

5

1 reference

15 November 2017

S M Mehendale

6

1 reference

15 November 2017

publication date

22 January 2010

1 reference

Transactions of the Royal Society of Tropical Medicine and Hygiene

15 November 2017

published in

1 reference

15 November 2017

volume

104

1 reference

15 November 2017

issue

6

1 reference

15 November 2017

page(s)

412-415

1 reference

Declining HIV incidence among patients attending sexually transmitted infection clinics in Pune, India

15 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2009.12.007

Polyherbal formulations with wide spectrum antimicrobial activity against reproductive tract infections and sexually transmitted pathogens.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2009.12.007

Phase I safety study of Praneem polyherbal vaginal tablet use among HIV-uninfected women in Pune, India

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2009.12.007

Acceptability research on female-controlled barrier methods to prevent heterosexual transmission of HIV: Where have we been? Where are we going?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2009.12.007

Expanded safety study of Praneem polyherbal vaginal tablet among HIV-uninfected women in Pune, India: a phase II clinical trial report

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2009.12.007

Elimination of high-risk human papillomavirus type HPV16 infection by 'Praneem' polyherbal tablet in women with early cervical intraepithelial lesions.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2009.12.007

Microbicide acceptability: insights for future directions from providers and policy makers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2009.12.007

Health practices and vaginal microbicide acceptability among urban black women.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2009.12.007

Acceptability of Carraguard, a candidate microbicide and methyl cellulose placebo vaginal gels among HIV-positive women and men in Durban, South Africa

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2009.12.007

Acceptability of PRO2000 vaginal gel among HIV un-infected women in Pune, India.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2009.12.007

Acceptability of tenofovir gel as a vaginal microbicide by US male participants in a Phase I clinical trial (HPTN 050).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2009.12.007

10.1016/J.TRSTMH.2009.12.007

7 January 2021

Identifiers

DOI

1 reference

15 November 2017

1 reference